相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder:-20℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 保质期:
Powder:-20℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 英文名:
Tiludronate disodium
- 库存:
现询
- 供应商:
北京索莱宝科技有限公司
- CAS号:
149845-07-8
- 规格:
10mg/5mg/1mg
| 规格: | 10mg | 产品价格: | ¥2990.0 |
|---|---|---|---|
| 规格: | 5mg | 产品价格: | ¥1790.0 |
| 规格: | 1mg | 产品价格: | ¥590.0 |
| 基本信息 | |
| CAS | No.149845-07-8 |
| 中文名称 | 替鲁Pi二钠 |
| 英文名称 | Tiludronate disodium |
| 别名 | Tiludronicaciddisodiumtert-ButylL-tyrosinate; |
| 分子式 | C7H7ClNa2O6P2S |
| 分子量 | 362.57 |
| 溶解性 | Soluble in Water |
| 纯度 | ≥98% |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:-20℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
| MDL | MFCD04039691 |
| SMILES | C1=CC(=CC=C1SC(P(=O)(O)[O-])P(=O)(O)[O-])Cl.[Na+].[Na+] |
| InChIKey | SKUHWSDHMJMHIW-UHFFFAOYSA-L |
| InChI | InChI=1S/C7H9ClO6P2S.2Na/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14;;/h1-4,7H,(H2,9,10,11)(H2,12,13,14);;/q;2*+1/p-2 |
| PubChem CID | 60936 |
| 靶点 | Osteoclast |
| 通路 | Immunology & Inflammation |
| 背景说明 | Tiludronate disodium 是破骨细胞空泡H(+)-ATP酶的有效抑制剂,可用于代谢性骨疾病的研究。 |
| 生物活性 | Tiludronate disodium 是一种口服活性双Pi盐,具有骨调节作用,可用于研究骨代谢性疾病。Tiludronate disodium 是破骨细胞空泡 H(+)-ATP 酶的强效抑制剂,具有抗骨吸收和抗炎特性。[1-4] |
| In Vitro | In vitro,tiludronate disodium added to bone tissue culture inhibits calcium release,lysosomal enzyme secretion and collagen matrix degradation when induced by various stimulators of bone resorption. At the cellular level,tiludronate disodium does not appear to exert its inhibitory effect on bone resorption by impairing either the recruitment,the migration or the fusion of osteoclast precursors.[3] The ability of tiludronate disodium to inhibit proton transport IC50 = 1.1 mM and in vesicles derived from osteoclasts IC50 = 466 nM. Tiludronate disodium also potently inhibited proton transport in yeast microsomal preparations(IC50 = 3.5 microM)and inhibited the activity of purified yeast V-ATPase.[4] |
| 细胞实验 | tiludronate disodium disodium counteract postmenopausal bone loss by decreasing bone resorption.[1] Local administration of tiludronate disodium disodium(1-3mg/kg,10days)promoted a protective effect against tissue destruction in EP in diabetic rats.[2] In vivo,tiludronate disodium exerts a dose-dependent inhibitory activity on bone resorption. By uncoupling bone resorption from bone formation,tiludronate disodium can induce a positive calcium and phosphate balance. When administered either continuously or intermittently to ovariectomized osteoporotic rats,tiludronate disodium promotes a significant increase in bone mass.[3] |
| 数据来源文献 | [1]. Reginster JY,et al. Prevention of postmenopausal bone loss by tiludronate. Lancet. 1989 Dec 23-30;2(8678-8679):1469-71. [2]. Nunes NLT,et al. Effects of local administration of tiludronic acid on experimental periodontitis in diabetic rats. J Periodontol. 2018 Jan;89(1):105-116. [3]. Bonjour JP,et al. Tiludronate: bone pharmacology and safety. Bone. 1995 Nov;17(5 Suppl):473S-477S. [4]. David P,et al. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Miner Res. 1996 Oct;11(10):1498-507. |
| 单位 | 瓶 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验细胞因子的检测细胞因子是由免疫细胞和某些非免疫细胞经刺激而合成、分泌的一类生物活性物质分泌的蛋白质,在体内广泛参与免疫调节及炎症反应、组织修复、刺激造血系统、刺激细胞的增殖与凋亡等重要生理活动,在抵抗外来病原及维持机体内环境平衡中均起重要作用。某些刺激因子也可导致一些细胞因子超量表达,或表达减少,从而参与疾病的发病及病理过程。故细胞因子的检测无论是对免疫学、分子生物学的基础研究,还是对阐明某些疾病的发病机理,指导临床治疗均有重要意义。细胞因子的检测方法一般分为免疫学、生物学及分子生物学测定
7 0 3~4 100豚鼠 5~7 10 5~7 100猴 - 0 6~7 100表10-16 各种动物急性放射病时某些感染并发症的发生率(%)(CeMeHOB)动物种类 照射剂量(伦) 扁桃体坏死性炎症 齿龈炎 肺 炎 肠 炎 结肠炎小鼠 700 0 0 20 20 0大鼠 500~700 0 0 10~20 10~30 0豚鼠 500~700 0 0 40 5 3狗 500~700
) 扁桃体坏死性炎症 齿龈炎 肺 炎 肠 炎 结肠炎 小鼠 700 0 0 20
技术资料暂无技术资料 索取技术资料










